Liminatus Pharma Inc. Class A-28LIMNWPreferred / convertible
13F holders, Q1 2026 (March 31)21holders −3
0new positions
3sold out
1famous investor
$0.05avg. 13F price*
At the end of Q1 2026, 21 institutions reported holding Liminatus Pharma Inc. Class A-28 (LIMNW) in their 13F filings, down 3 from Q4 2025. 0 opened new positions and 3 sold out. The largest holders were Aristeia Capital, L.L.C. ($16K), Linden Advisors LP ($13K) and Saba Capital Management, L.P. ($11K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Liminatus Pharma Inc. Class A-28
- CUSIP
- 53271X116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $1K |
All 13F filers, Q4 2025 → Q1 2026: 295 shares bought and 873,576 shares sold, net −873,281 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Aristeia Capital, L.L.C. | — | No change | 319,510 | $16K |
| Linden Advisors LP | — | No change | 268,199 | $13K |
| Saba Capital Management, L.P. | — | No change | 233,761 | $11K |
| Polar Asset Management Partners Inc. | — | No change | 122,688 | $6K |
| Moore Capital Management, LP | — | No change | 125,000 | $5K |
| MMCAP International Inc. SPC | — | No change | 111,745 | $4K |
| D. E. Shaw & Co. | — | No change | 83,353 | $3K |
| Blue Owl Capital Holdings LP | — | No change | 50,000 | $2K |
| Periscope Capital Inc. | — | No change | 47,500 | $2K |
| Wolverine Asset Management LLC | — | Reduce -37.3% | 39,373 | $2K |
| Toronto Dominion Bank | — | No change | 35,100 | $1K |
| LMR Partners LLP | — | No change | 29,961 | $1K |
| Arena Capital Advisors, LLC- CA | — | No change | 29,166 | $1K |
| Flow Traders U.S. LLC | — | No change | 13,110 | $1K |
| Jane Street Group, LLC | — | No change | 24,274 | $971 |
| Limestone Investment Advisors LP | — | No change | 22,562 | $902 |
| GTS Securities LLC | — | Reduce -29.2% | 21,029 | $841 |
| Dupont Capital Management Corp. | — | No change | 6,250 | $306 |
| UBS Group AG | — | Add +7.0% | 4,507 | $180 |
| HGC Investment Management Inc. | — | No change | 1,250 | $50 |
| Clear Street Group Inc. | — | Reduce -100.0% | 100 | $4 |
"% of holder's portfolio" is LIMNW's weight in each manager's 13F, not the share of Liminatus Pharma Inc. Class A-28 the manager owns.